State-of-the-art acute phase management of Kawasaki disease after 2017 scientific statement from the American Heart Association
Kawasaki disease (KD) has become the most common form of pediatric systemic vasculitis. Although patients with KD received intravenous immunoglobulin (IVIG) therapy, coronary arterial lesions (CALs) still occurred in 5%–10% of these patients during the acute stage. CALs may persist and even progress...
Main Authors: | Yi-Ching Liu, Ming-Tai Lin, Jou-Kou Wang, Mei-Hwan Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-12-01
|
Series: | Pediatrics and Neonatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957217305922 |
Similar Items
-
Falling Through the Cracks: The Current Gap in the Health Care Transition of Patients With Kawasaki Disease<subtitle>A Scientific Statement From the American Heart Association</subtitle>
by: Nagib Dahdah, et al.
Published: (2021-10-01) -
Comparison of risk scores for predicting intravenous immunoglobulin resistance in Taiwanese patients with Kawasaki disease
by: Chi-Nan Huang, et al.
Published: (2021-10-01) -
Assessing cardiac metabolism: A scientific statement from the American Heart Association
by: Taegtmeyer, H, et al.
Published: (2016) -
Acute Coronary Syndrome in Older Adults: an Update from the 2022 Scientific Statement by the American Heart Association
by: Stefano Cacciatore, et al.
Published: (2023-01-01) -
Rotational Atherectomy and Stent Implantation in an 11-Year-Old Boy with a History of Kawasaki Disease
by: Yi-Chih Wang, et al.
Published: (2016-06-01)